Approved Formulary
Add Formweb to your mobile device
Approved Formulary
HIGH ALERT: Please read the COMMENTS very carefully.
Black Box Warning: Narcan/resusitative equipment available upon initiation
Search results for:
MORPHINE INJECTION
MORPHINE INJECTION
- PALS Drug Administration Guidelines PALS Morphine Infusion
- Drug Administration Guidelines Click here for administration guidelines
- Black Box Warning: Narcan/resusitative equipment available upon initiation
| Drug Name | Form | Strength | Non-Formulary | Notes |
|---|---|---|---|---|
| DURAMORPH | INJECTION | 0.5 mg/ml PF | ||
| ASTRAMORPH | INJECTION | 1 mg/ml PF | ||
| DURAMORPH | INJECTION | 1 mg/ml PF | ||
| MORPHINE SULFATE | INJECTION | 2 mg/ml | ||
| MORPHINE SULFATE | INJECTION | 4 mg/ml | ||
| MORPHINE SULFATE | INJECTION | 10 mg/ml | ||
| INFUMORPH | INJECTION | 25 mg/ml PF | ||
| MORPHINE IV PCA | IV PCA | 100 MG/100 ML |
View Other Therapeutic Options: Opioid Agonists:
280808
High Alert Drug
Last updated: Aug. 30, 2018
Class II
Errors have resulted from mix-ups between the abbreviations "MgSO4" for magnesium sulfate and "MS" or "MSO4" for morphine sulfate. Double-checks for appropriateness of drug/dose/pump setting/line placement must be performed during PCA/Epidural use.
The High Risk/High Alert Medication Policy may be found by using the search function in Policies and Procedures.